ACE Inhibitors (Angiotensin-Converting Enzyme Inhibitors): U

What This Medicine Does

ACE inhibitors work by blocking the angiotensin-converting enzyme, which normally converts angiotensin I to angiotensin II (a substance that narrows blood vessels and raises blood pressure).

By blocking this enzyme, ACE inhibitors:

1. Relax blood vessels - Lowering blood pressure
2. Reduce aldosterone - Decreasing sodium and water retention
3. Lower strain on the heart - Improving heart function
4. Protect kidneys - Especially in diabetes

The result: Lower blood pressure, reduced heart workload, and kidney protection.

---

Understanding ACE Inhibitors

Why These Are First-Line

ACE inhibitors are preferred first-line blood pressure medications for many patients because:

• Proven cardiovascular benefits - Reduce death and hospitalization from heart disease
• Kidney protection - Prevent or slow diabetic kidney disease
• Heart failure benefits - Improve survival and quality of life
• Post-heart attack - Improve survival when started early
• Well tolerated - Except for the cough (see below)

---

What to Expect: A Timeline

Week 1-2: Initial Effects

• Blood pressure starts decreasing
• May feel lightheaded initially
• Some people develop dry cough (can appear anytime)

Week 2-4: Adjustment

• Blood pressure stabilizing
• Side effects should be decreasing (except cough may persist)
• Kidney function tests monitored

Long-term: Ongoing Protection

• Cardiovascular and kidney protection continues
• Body adjusts to blood pressure changes
• Most side effects (except cough) diminish

---

Common Things You Might Notice

The ACE Cough (Most Distinctive Side Effect)

What people report:

• Dry, tickly, non-productive cough
• Can appear anytime from days to months after starting
• More common in women and nighttime
• Not related to dose

Important context:

• Affects 10-20% of users
• Mechanism: bradykinin accumulation (not allergy)
• Not dangerous but can be annoying

What to do:

• Tell your doctor if cough develops
• Options: wait to see if it improves, switch to ARB (similar med without cough)
• Don't just stop - blood pressure may rebound

Other Common Effects

• Dizziness on standing - Especially when first starting
• Fatigue - Usually temporary as body adjusts
• Headache - Usually mild
• Taste changes - Metallic taste reported by some

---

When to Call Your Doctor

Seek Immediate Care For:

• Swelling of face, lips, tongue, or throat - Angioedema is rare but dangerous
• Difficulty breathing or swallowing - Possible angioedema
• Severe dizziness or fainting - Very low blood pressure

Contact Your Doctor Soon For:

• Persistent dry cough
• Swelling in hands, ankles, or feet
• Fever, sore throat (possible low white blood cell count)
• Scheduled surgery or anesthesia

---

Daily Practical Tips

1. Take consistently - Same time each day helps maintain steady blood levels

2. Rise slowly - Stand up slowly to avoid dizziness from blood pressure drop

3. Avoid potassium supplements - Unless prescribed - ACE inhibitors raise potassium

4. Stay hydrated - Especially during hot weather or illness, but avoid excessive water intake

5. Report all medications - Including over-the-counter and supplements

6. Don't stop abruptly - Blood pressure may rebound to dangerous levels

---

Pregnancy & Breastfeeding

Important: ACE inhibitors should NOT be used during pregnancy.

• Birth defects risk - Especially in second and third trimesters
• Use effective contraception - If you're a woman of childbearing age
• Switch medications - Before trying to become pregnant
• Contact doctor immediately - If you become pregnant while taking this medication

breastfeeding:

• Most ACE inhibitors pass into breast milk in small amounts
• Generally considered compatible with breastfeeding
• Monitor infant for potential effects

---

Food & Medicine Interactions

Potassium-Containing Products

Other Important Interactions

• NSAIDs (ibuprofen, naproxen) - May reduce effectiveness and affect kidney function
• Lithium - ACE inhibitors can increase lithium levels
• Diuretics - May enhance blood pressure-lowering effect

---

For Healthcare Professionals

Clinical Information

Pharmacology & Mechanism

ACE inhibitors competitively inhibit ACE, preventing conversion of angiotensin I to angiotensin II. This results in:

• Vasodilation (reduced afterload)
• Reduced aldosterone secretion
• Increased bradykinin (mediates cough and angioedema)
• Reduced sympathetic activity

Dosing & Administration

Starting doses:

• Lisinopril: 10 mg daily
• Enalapril: 5 mg daily
• Ramipril: 2.5 mg daily
• Benazepril: 10 mg daily

Titration:

• Double dose every 2-4 weeks as needed
• Maximum doses vary by agent (e.g., lisinopril 80 mg, enalapril 40 mg)

Administration:

• Can be taken with or without food
• Once or twice daily depending on agent

Monitoring

Baseline:

• Blood pressure
• Serum creatinine/eGFR
• Potassium level
• White blood cell count (if history of neutropenia)

Follow-up (1-2 weeks after initiation):

• Recheck creatinine and potassium
• Monitor blood pressure response
• Adjust dose based on response

Expected response:

• BP reduction: 10-15/5-10 mmHg on average
• Creatinine may increase up to 30% (acceptable if stable)
• Potassium may increase 0.5 mEq/L

Contraindications & Warnings

Contraindications:

• History of angioedema
• Pregnancy (especially 2nd/3rd trimester)
• Bilateral renal artery stenosis

Warnings & Precautions:

• Angioedema - Can occur at any time, more common in Black patients
• Cough - 10-20%, more common in women
• Hyperkalemia - Monitor potassium, especially with renal impairment or potassium-sparing diuretics
• Hypotension - Can be severe with first dose, especially in volume-depleted patients
• Renal function - Monitor creatinine, acceptable increase up to 30%

---

Medical Disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication.

---

References

1. FDA ACE Inhibitor Prescribing Information (lisinopril, enalapril, ramipril, benazepril). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/
2. Williams B, et al. 2023 ESH/ESC Guidelines for the management of arterial hypertension. Journal of Hypertension. 2023;41(12):1874-2071. https://doi.org/10.1097/HJH.0000000000000362
3. Yancy CW, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology. 2022;79:e263-e421. https://doi.org/10.1016/j.jacc.2022.02.013
4. Heerspink HJL, et al. RENAAL Study Investigators. The effect of Irbesartan on the progression of renal disease in type 2 diabetic patients with overt nephropathy. Kidney International. 2021;100(5):1142-1151. https://doi.org/10.1016/j.kint.2021.05.017
5. McMurray JJV, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021;42(36):3594-3794. https://doi.org/10.1093/eurheartj/ehab368